US20210393753A1

Fgl2 neutraling cell therapy and methods of use thereof

University of Texas System

Abstract

Provided herein is an FGL2 neutralization cell therapy comprising immune cells expressing a FGL2 neutralization construct. Further provided are methods for the treatment of cancer comprising administering the FGL2 neutralization cell therapy.

University: University of Texas System
Assignee: Board Of Regents, The University Of Texas System
Inventor: Shulin Li
Priority date: November 06, 2018
Filing date: November 06, 2019
Publication date: December 23, 2021
Language: en
PDF source: https://patentimages.storage.googleapis.com/5f/0e/6e/70d180505986b7/US20210393753A1.pdf
Metadata fetched: August 29, 2026 00:28